ライフサイエンスコーパス: implantation

1 ceptable quality of life at the time of LVAD implantation.

2 ive radiological performance with successful implantation.

3 artery disease in a child with PCI with BRS implantation.

4 usable pending histology, or not usable for implantation.

5 (6 months to 4 years) phases post-pacemaker implantation.

6 nt of functional redundancy following embryo implantation.

7 aortic regurgitation and need for pacemaker implantation.

8 E2 exposure increased MAP after pellet implantation.

9 s warrant greater consideration during organ implantation.

10 beats arising from that site by week 1 after implantation.

11 erall effect on all-cause mortality with ICD implantation.

12 hysiological target mapping during electrode implantation.

13 the infarct-related artery and before stent implantation.

14 has been preserved for five months after the implantation.

15 uded if they had previously undergone B-KPro implantation.

16 espite favorable glycemic control after LVAD implantation.

17 operative status, especially after binocular implantation.

18 ntinuous-flow left ventricular assist device implantation.

19 les-is a vital milestone during human embryo implantation.

20 est risk HCM patients can benefit from S-ICD implantation.

21 All 6 participants underwent successful implantation.

22 ation of secondary defects created during He implantation.

23 drug-eluting stents in the early years after implantation.

24 w (CF) left ventricular assist device (LVAD) implantation.

25 or counseling patients both before and after implantation.

26 nation and underestimated survival post-LVAD implantation.

27 res performed with or without concurrent GDD implantation.

28 ated the risk of clinical worsening and LVAD implantation.

29 rdiac magnetic resonance prior to CRT device implantation.

30 mean Hounsfield unit on survival after LVAD implantation.

31 AMTS5 to ADAMTS4 gene expression after stent implantation.

32 be unsuitable for ventricular assist device implantation.

33 ients were enrolled and underwent successful implantation.

34 or extraction >/=12 months after the de novo implantation.

35 little is known about ECM changes post-stent implantation.

36 is (KPro) and glaucoma drainage device (GDD) implantation.

37 ntiplatelet therapy after drug-eluting stent implantation.

38 empirical oral anticoagulation following BPV implantation.

39 nd often result in permanent pacemaker (PPM) implantation.

40 (88.6%) received CRT-D at the time of device implantation.

41 received 1 or more everolimus-eluting stent implantation.

42 ty or impediment to coronary sinus (CS) lead implantation.

43 efect concentrations created by the hydrogen implantation.

44 (D) were defined as candidates for toric IOL implantation.

45 drainage devices (GDDs) inserted before KPro implantation.

46 to ectopic bone formation under subcutaneous implantation.

47 f the first signs of inflammation after LVAD implantation.

48 life-threatening complications and pacemaker implantation.

49 eater adverse LV remodeling, and more device implantations.

50 e no deaths, strokes, or permanent pacemaker implantations.

51 associated with increased likelihood of ICD implantation, 1-year ICD implantation rates remain very

52 < 0.001) due to lower rates of second valve implantation (12.7% vs. 24.4%; p = 0.007) and post-proce

53 was associated with lower rates of pacemaker implantation (2.9% versus 8.0%; P<0.001) and blood trans

54 The mean age was 75 years at the time of implantation; 25.3% were <70 years of age and 25.7% were

55 in successful fertilization (10% decrease), implantation (31%), clinical pregnancy (41%), and live b

56 976 patients undergoing continuous-flow-LVAD implantation, 386 patients (3.9%) required an RVAD withi

57 acutely after transcatheter pulmonary valve implantation (39 versus 10 mm Hg; P<0.001).

58 or Xience metallic drug-eluting stent (DES) implantation (Abbott Vascular, Santa Clara, California)

59 The need for RVAD implantation after LVAD is associated with indices of gl

60 underwent cataract operation with toric IOL implantation after posterior segment surgery.

61 heart team, were treated by transfemoral THV implantation (age 82.7 +/- 5.5 years, 67.5% female, 68.0

62 otent stem cell-based model, termed the post-implantation amniotic sac embryoid, to recapitulate earl

63 myopathy Questionnaire-12 summary scores pre-implantation and 3 months postoperatively.

64 oup A was significantly older at the time of implantation and achieved higher graft function at postt

65 as drug-eluting stents within 2 years after implantation and between 1 and 2 years.

66 ysis revealed similarities between embryonic implantation and cancer cell adhesion, which suggests th

67 ely half of the proposed sample received DBS implantation and completed the double-blind phase.

68 However, DAPS rapidly lost proteoglycan post-implantation and did not integrate into adjacent vertebr

69 ll population during the embryonic window of implantation and find that the majority of cells are tis

70 ACS in patients who previously received PIOL implantation and have a low corneal endothelial cell cou

71 ing language lateralization before electrode implantation and is especially useful for excluding unex

72 placement (AVR) allows for larger prosthesis implantation and may be an important adjunct to surgical

73 high-resolution oculography before and after implantation and monitoring the patient for more than 4

74 cardiovascular-implantable electronic device implantation and necessitates removal of all hardware fo

75 ing with longer time intervals between stent implantation and presentation.

76 derwent diaphragm electromyography electrode implantation and SH surgery.

77 y infertile because of defects in blastocyst implantation and stromal cell decidualization.

78 ecretions play important roles in blastocyst implantation and stromal cell decidualization.

79 Cutaneous implantation and systemic mycoses are neglected diseases

80 Risk factors for RVAD implantation and the combined end point of RVAD or death

81 (21.7%) after left ventricular assist device implantation and was associated with a lower 1-year (53%

82 plant on ambulatory monitoring, 44 after ICD implantation, and 22 on both.

83 pends on appropriate patient selection, lead implantation, and device programming.

84 ionic-electronic conductors (MIECs), He-ion implantation, and superconductors.

85 ives to the standard 3-incision subcutaneous implantation, and the 2-incision technique resulted in s

86 Intramuscular implantation appeared more effective than intra-arterial

87 These results demonstrate that an s.c. implantation approach in a 3D carrier scaffold seeded wi

88 ata pertaining to the clinical impact of PPM implantation are controversial.

89 the H(+) energy and fluence chosen for GaAs implantation are similar to that of protons originating

90 tcomes of BVS following the first year after implantation are unknown.

91 ation beyond 1 year after drug-eluting stent implantation as compared with 1-year DAPT remain controv

92 igher rates of ischemic cardiomyopathy, LVAD implantation as destination therapy, and increased basel

93 this study population, an age cutoff for ICD implantation at </=70 years yielded the highest survival

94 dergoing first-time secondary prevention ICD implantation between 2006 and 2009 in 956 U.S. hospitals

95 undergoing pulmonary artery pressure sensor implantation between June 1, 2014, and December 31, 2015

96 e novo cardiac implantable electronic device implantations between January 1, 2000, and December 31,

97 robustly engraft in both pig and cattle pre-implantation blastocysts but show limited contribution t

98 implantable cardioverter-defibrillator (ICD) implantation, but patient stratification remains trouble

99 Toric intraocular lens (IOL) implantation can be an effective method for correcting c

100 the auditory cortex for which early cochlear implantation can effectively compensate.

101 MVRS ePTFE cordal implantation can reduce the invasiveness and morbidity o

102 creased risk of new-onset HF after pacemaker implantation compared with those without AVB.

103 s, bleeding, and new pacemaker/defibrillator implantation demonstrated no significant differences bet

104 gs, originate during weeks 2-3 of early post-implantation development.

105 bolic control mechanism underlying early pre-implantation development.

106 After IOL implantation during infancy, the rate of myopic shift oc

107 make refractive outcomes challenging for IOL implantation during infancy.

108 Ten years after implantation, ECD had decreased by >/=25% in 7.9% and 6.

109 cardiopatches robustly engraft, maintain pre-implantation electrical function, and do not increase th

110 CVE rates was performed for ablation, device implantation, electrophysiology study, lead extraction,

111 active X chromosomes in both early human pre-implantation embryos and naive human embryonic stem cell

112 om naive pluripotency in cultured human post-implantation embryos triggers amniotic cavity formation

113 ve no impact on the success of the toric IOL implantation, even in keratoconus.

114 ed in all patients who received the surgical implantation except in one patient who discontinued befo

115 e for assisted reproductive technology, with implantation failure occurring in approximately 50% of i

116 outcome of intracorneal ring segment (ICRS) implantation followed by cross-linking in pediatric kera

117 14 years (mean age 12.3 years) received ICRS implantation followed by CXL.

118 , they can be cut or reshaped at the time of implantation for applications in small or physically con

119 ime course for developing HF after pacemaker implantation for cAVB.

120 cataract surgery with intraocular lens (IOL) implantation for infants enrolled in the Infant Aphakia

121 after left ventricle assisted device (LVAD) implantation for patients suffering from heart failure (

122 nts with Brugada syndrome and 2) whether ICD implantation for primary prevention is associated with i

123 of 3 hours after extracorporeal life support implantation for the remaining ones.

124 Successful device implantation free of cardiovascular mortality, stroke, a

125 d patients undergoing dual-chamber pacemaker implantation from 2008 to 2014.

126 At day 10-12 after implantation, FUS-induced BTB disruption using 690kHz ul

127 with periods of sinus rhythm at the time of implantation had a better survival than those in refract

128 of cross-modal plasticity following cochlear implantation has been restricted due to incompatibility

129 ata available for 12 months before and after implantation (HR: 0.66; 95% CI: 0.57 to 0.76; p < 0.001)

130 Visian ICL implantation improves visual function in special needs c

131 h, or implantable cardioverter-defibrillator implantation in a cohort of 2622 stable patients with an

132 were shown to be highly resorbable following implantation in a porcine femoral artery.

133 Guidelines specified recommendations for ICD implantation in ACHD patients for the first time.

134 ing of left ventricular assist device (LVAD) implantation in advanced heart failure patients not on i

135 Boston type 1 keratoprosthesis implantation in children is associated with a substantia

136 ons of Boston type 1 keratoprosthesis (KPro) implantation in children.

137 ed to implantable cardioverter defibrillator implantation in comparison with men.

138 long-term outcomes after drug-eluting stents implantation in de novo coronary lesions.

139 aemic heart disease undergoing planned stent implantation in de-novo, native coronary lesions.

140 The molecular changes that support implantation in eutherian mammals are necessary to estab

141 between term pregnancy in the marsupials and implantation in eutherian mammals using the gray short-t

142 consistent with the pattern observed during implantation in eutherian mammals.

143 by an inflammatory response consistent with implantation in humans and mice.

144 ears after unilateral intraocular lens (IOL) implantation in infants.

145 pout of patients over time because of device implantation in patients with more severe LV dysfunction

146 ssment and their association with 1-year ICD implantation in post-MI patients with low EF.

147 between the opossum attachment reaction and implantation in rabbits and humans.

148 ations after Boston keratoprosthesis type II implantation in the largest single-center case series wi

149 y any motor deficit caused by microelectrode implantation in the motor cortex of healthy rats compare

150 e powerful predictors of outcomes after LVAD implantation in this data set.

151 urpose is to report the outcome of toric IOL implantation in two cases - a patient with scleral-buckl

152 iac death undergo cardioverter-defibrillator implantation; in patients with severe symptoms related t

153 We demonstrate that key markers of implantation, including Heparin binding EGF-like growth

154 catheterization, balloon dilation, and stent implantation into aorto-iliac/visceral arteries and the

155 After implantation into pig knees, hMSCs labeled with group 1

156 hibited a 30-fold increase in viability upon implantation into rat striatum compared to neurons gener

157 3.5 months post-implantation into SCID mice, the micro-computed tomograp

158 intrinsic human rate of maturation, despite implantation into the injured rodent spinal cord, yet th

159 developed, rats underwent STN-DBS electrode implantation ipsilateral to the vector-injected SN.

160 These cases demonstrate that toric IOL implantation is a predictable and safe method for the co

161 Transcatheter valve-in-valve implantation is an established therapy for high-risk pat

162 egions by visual speech from before to after implantation is associated with better speech understand

163 coagulant-related lifetime risk of bleeding, implantation is associated with upfront complications.

164 Because device implantation is not easily reversible, as well as the hi

165 s for implantable cardioverter defibrillator implantation is one of the most challenging issues in th

166 ng the retention of cell therapies following implantation is vital and often achieved by labelling ce

167 Cell implantation markedly improved vascularity and cardiac f

168 An intact t-system at the time of LVAD implantation may constitute a precondition and predictor

169 h block and the need for permanent pacemaker implantation may have a significant detrimental associat

170 Using an orthotopic implantation model in mice, which uniquely recapitulates

171 Our in vivo studies with orthotopic implantation models demonstrated a robust increase in ge

172 ional endovascular stent graft repairs, post-implantation movement of the endoprosthesis has been des

173 aphies performed in the 3 months before LVAD implantation (n=143).

174 nade, and feasibility, defined as successful implantation of 1 or more MitraClip devices and reductio

175 ning bleeding of 5%, and post-TAVI pacemaker implantation of 12%.

176 Co-implantation of 4T1 cells with CYP4A10(high) macrophages

177 largement and expansive remodeling following implantation of a bioresorbable vascular scaffold (BVS),

178 This complication can usually be averted by implantation of a cardioverter-defibrillator in appropri

179 tive feet or hand movements while undergoing implantation of a deep brain stimulator.

180 d currently the only effective prevention is implantation of a defibrillator (ICD).

181 man heart samples routinely discarded during implantation of a left ventricular assist device.

182 Implantation of a MSA around the gastroesophageal juncti

183 netically, herein we describe the successful implantation of a novel magnetic oculomotor prosthesis i

184 ation biopsy of the tumor immediately before implantation of a radioactive iodine 125 plaque as treat

185 of the right sensorimotor cortex and chronic implantation of a stimulating electrode into the right M

186 Implantation of ADD with placement of GISC patch graft o

187 tment and were successfully managed with the implantation of Ahmed drainage devices.

188 The implantation of Ahmed valve proved to be effective treat

189 hrombus-capturing efficacy for 5 weeks after implantation of an absorbable inferior vena cava (IVC) f

190 lemic swine model of femoral restenosis, the implantation of an FP-PES resulted in lower levels of ne

191 Second, to evaluate whether implantation of an ICD is associated with a clinical ben

192 Implantation of an ICD with or without CRT.

193 who had "failed" conventional CRT underwent implantation of an LV endocardial pacing electrode and a

194 brain circuits without the need for surgical implantation of any device.

195 A total of 48 eyes in 46 patients with implantation of aphakic, snap-on type 1 Boston KPros per

196 Eyes that underwent total PPVs during implantation of aphakic, snap-on, type I Boston KPros ha

197 The implantation of at least one device was successful in al

198 d in vivo force production are enhanced when implantation of bioconstructs is followed by an exercise

199 retrospective study with over 5000 patients, implantation of both trifocal IOL models provided good f

200 Co-implantation of CAFs and tumor cells with either intact

201 Traumatic implantation of contaminated plant material is the most

202 implantation of intrathecal infusion pumps, implantation of deep brain stimulation hardware, and gen

203 We randomly assigned patients (1:1) to implantation of either a sirolimus-eluting bioresorbable

204 DBS involves the surgical implantation of electrodes into specific nuclei in the b

205 OLFOX was tested in a mouse model with cecal implantation of green fluorescent protein-labeled syngen

206 al fluid shunts, cerebrospinal fluid drains, implantation of intrathecal infusion pumps, implantation

207 sent visual and functional results following implantation of iris prosthesis combined with cataract s

208 was significantly better in group 2, if the implantation of kidneys was delayed >48 hours (P < 0.01)

209 eviewed 341 consecutive adults who underwent implantation of LVAD from 2007 to 2016.

210 s and 26 patients with chronic HF undergoing implantation of LVADs.

211 Co-implantation of M2-like macrophages (MLCs) promoted GSC-

212 ct surgery were divided into four groups for implantation of one of the IOLs under evaluation.

213 reast cancer) were developed by subcutaneous implantation of patient tumor fragments.

214 South and Central America, follows traumatic implantation of saprophytic fungi and frequently require

215 Implantation of tension-stimulated tissues results in ne

216 rgery 1 month after their baseline visit for implantation of the dual lead DBS system.

217 An implantation of the embryo before reaching the uterus co

218 resents an essential step for the successful implantation of the embryo; however, the molecular mecha

219 re type of ectopic pregnancy, where there is implantation of the gestational sac onto the anterior wa

220 rly predisposing it to be a site of improper implantation of the gestational sac.

221 of fifty-eight patients receiving bilateral implantation of the study intraocular lens were analysed

222 Implantation of these human bipotential CD34(+) progenit

223 in this complex population very early after implantation of Ultimaster drug-eluting stent.

224 sion, the possible impact of oversized stent implantation on arterial wall injury has not been system

225 ffects of short-term ozone inhalation during implantation on fetal growth outcomes and to explore the

226 ulsification and in-the-bag intraocular lens implantation on intraocular pressure control and the ble

227 es who would otherwise meet criteria for ICD implantation on the basis of symptoms or left ventricula

228 ing risk of death, ventricular assist device implantation, or cardiac transplantation.

229 to conventional primary PCI, including stent implantation, or postconditioning performed as 4 repeate

230 To assess whether peri-implantation ozone exposure resulted in sustained pulmon

231 quiring transfusion, and permanent pacemaker implantation (P<0.001).

232 AR at the final visit after intraocular lens implantation (p=0.000).

233 metabolic change that occurs during the peri-implantation period, and throughout early pregnancy, is

234 ocysts but show limited contribution to post-implantation pig embryos.

235 Submuscular implantation places the pulse generator underneath the s

236 atched comparison of THVs for valve-in-valve implantations, Portico and CoreValve demonstrated differ

237 ue damage and inflammation, making long-term implantation possible.

238 tor-sarcolemma distances at the time of LVAD implantation predicted high post-LVAD left ventricular e

239 activation of CGRP(PBN) neurons before tumor implantation prevents anorexia and loss of lean mass, an

240 re were among the patients undergoing device implantation procedures, with cardiac tamponade being th

241 cedure were among patients undergoing device implantation procedures.

242 n March 2015, we obtained procedural data on implantation procedures.

243 After stent implantation, proteins involved in regulating calcificat

244 ons (2.2% versus 6.5%), as well as pacemaker implantation rate (12.0% versus 15.2%), were similar.

245 d likelihood of ICD implantation, 1-year ICD implantation rates remain very low even among patients w

246 Our data suggest that the implantation reaction that occurs in eutherians is deriv

247 Embryo implantation remains a significant challenge for assiste

248 Embryo implantation requires a hospitable uterine environment.

249 LVAD implantation resulted in a remarkable decrease in hemogl

250 eas rates of cardiac tamponade and pacemaker implantation significantly increased.

251 In particular, the implantation stage of pregnancy is considered a key wind

252 etected in the uterine epithelium and in pre-implantation-stage embryos, respectively.

253 ime-dependent EF reassessment and 1-year ICD implantation, stratified by revascularization status dur

254 A for treatment of arteries ex vivo prior to implantation subsequently attenuating immune reaction in

255 Implantation success (1 valve in the intended location)

256 In vivo implantation suggests vascularization of 3D bioprinted c

257 Although implantation surgery remains challenging, new developmen

258 a in 1 case underwent prosthetic iris device implantation surgery.

259 ts undergoing left ventricular assist device implantation surgery.

260 The presented implantation techniques are feasible alternatives to the

261 Four implantation techniques were used depending on physician

262 m HR, is greater in candidates for toric IOL implantation than in the general population.

263 received four weeks of STN DBS or electrode implantation that remained inactive.

264 Upon nerve conduit implantation, the NCSC group showed significantly higher

265 ircadian disruption from the time of uterine implantation through weaning.

266 Filters with extended implantation times present a challenge to retrieval, whe

267 ive complications of the reported technique, implantation tumor development, local tumor recurrence,

268 the serratus anterior muscle and subfascial implantation underneath the fascial layer on the anterio

269 e procedure and device success 30 days after implantation using the Mitral Valve Academic Research Co

270 Among patients with prior stent implantation, VLST was causal in 20% of MI cases and pre

271 Implantation volumes continue to grow, but several chall

272 mean (SD) age of women at their initial mesh implantation was 56.2 (13.0) years.

273 Successful device implantation was achieved in 28 patients (93.3%).

274 In our analysis, ICD implantation was associated with improved survival (over

275 Progression of IF/TA from implantation was noted in 6 (24%) of 25 ABOi and 6 (17.6

276 An optimal age cutoff for ICD implantation was present at </=70 years.

277 Need for permanent pacemaker implantation was significantly higher with the repositio

278 In 3,822 consecutive cases, implantation was successful in 3,653 (95.6%), with a med

279 ntiplatelet therapy after drug-eluting stent implantation, we avoid a common pitfall in traditional m

280 d outcomes after extracorporeal life support implantation were analyzed.

281 d type (biological/mechanical) and time from implantation were collected for each patient.

282 during pre-defined periods before and after implantation were compared using the Andersen-Gill exten

283 Two patients with a previous iris-claw PIOL implantation were enrolled.

284 s of follow-up or a history of previous KPro implantation were excluded.

285 ecommendations for CRT at the time of device implantation were included in this study.

286 ctomy combined with primary intraocular lens implantation were included.

287 19 (95%) of 20 patients alive 30 days after implantation were NYHA class I or II.

288 d cardiomyopathy undergoing prophylactic ICD implantation were prospectively enrolled (age 62+/-11 ye

289 Records of patients having undergone KPro implantation were reviewed.

290 Records of patients having undergone B-KPro implantation were reviewed.

291 Implantations were completed in 23 centers.

292 Endometrial SLC5A1 expression during the implantation window was attenuated in patients with recu

293 a unilateral cataract were randomized to IOL implantation with an initial targeted postoperative refr

294 d times to events up to 3 years after device implantation with Cox regression models.

295 of standalone ab interno gelatin microstent implantation with mitomycin C (MMC) versus trabeculectom

296 nt linear chronic EC loss was reported after implantation with myopic or toric iris-fixated pIOLs.

297 age, 87% female) underwent successful device implantation with no deaths, strokes, bleeding, tamponad

298 was the most potent in inhibiting embryonic implantation within non-cytotoxic concentrations.

299 After contemporary everolimus-eluting stent implantation, women and minorities experience a similar

300 After pacemaker implantation, younger patients (</=55 years of age) and